Chairman and Executive Director Cai Dongchen has increased his stake in SinoPharm Group (01093.HK) by 6,706,000 shares at a price of HK$8.85 per share.

According to the latest information from the Wisdom Financial APP, the Hong Kong Stock Exchange showed that on December 23, Chairman and Executive Director Cai Dongchen increased his holdings of Sino Biopharmaceutical Group (01093.HK) by 6.706 million shares, with a price of 8.85 Hong Kong dollars per share, for a total amount of approximately 59.3481 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 2.917 billion shares, and the latest shareholding ratio is 25.31%.